Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 23 Feb 24 424B5 Prospectus supplement for primary offering
- 7 Dec 23 424B5 Prospectus supplement for primary offering
- 5 Dec 23 424B5 Prospectus supplement for primary offering
- 15 Aug 23 424B5 Prospectus supplement for primary offering
- 17 Jul 23 EFFECT Notice of effectiveness
-
10 Jul 23 F-3 Shelf registration (foreign)
Filing view
External links
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
We have issued our report dated July 10, 2023 with respect to the consolidated financial statements of ImmunoPrecise Antibodies Ltd. included in the Annual Report on Form 40-F for the year ended April 30, 2023, which is incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned report in this Registration Statement, and to the use of our name as it appears under the caption "Experts".
/s/ GRANT THORNTON LLP
Houston, Texas
July 10, 2023